The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Arcus Biosciences Inc shares valued at $201,200 were purchased by KANEKO YASUNORI on Feb 27 ’25. At $10.06 per share, KANEKO YASUNORI acquired 20,000 shares. The insider’s holdings grew to 28,400 shares worth approximately $0.24 million following the completion of this transaction.
Also, ROSEN TERRY J purchased 19,800 shares, netting a total of over 201,465 in proceeds. Following the buying of shares at $10.18 each, the insider now holds 2,554,160 shares.
Before that, GILEAD SCIENCES, INC. had added 1,363,636 shares to its account. In a trade valued at $14,999,996, the 10% Owner bought Arcus Biosciences Inc shares for $11.00 each. Upon closing the transaction, the insider’s holdings increased to 1,363,636 shares, worth approximately $270.88 million.
As published in a research note from H.C. Wainwright on February 26, 2025, Arcus Biosciences Inc [RCUS] has been rated up from a Neutral to a Buy and the price target has been revised to $24 from $18. Analysts at H.C. Wainwright started covering the stock with ‘”a Neutral”‘ outlook in a report released in late October. As of October 08, 2024, Wells Fargo has initiated its “an Overweight” rating for RCUS. Earlier on November 18, 2022, BofA Securities initiated its rating. Their recommendation was “a Neutral” for RCUS stock.
Analyzing RCUS Stock Performance
On last trading session,, Arcus Biosciences Inc [NYSE: RCUS] plunged -1.49% to $8.62. The stock’s lowest price that day was $8.36, but it reached a high of $8.75 in the same session. During the last five days, there has been a drop of approximately -0.92%. Over the course of the year, Arcus Biosciences Inc shares have dropped approximately -47.28%. Shares of the company reached a 52-week high of $15.61 on 01/07/25 and a 52-week low of $6.50 on 04/07/25.
Support And Resistance Levels for Arcus Biosciences Inc (RCUS)
According to the 24-hour chart, there is a support level at 8.40, which, if violated, would cause prices to drop to 8.19. In the upper region, resistance lies at 8.79. The next price resistance is at 8.97. RSI (Relative Strength Index) is 44.32 on the 14-day chart, showing neutral technical sentiment.
Is Arcus Biosciences Inc subject to short interest?
Stocks of Arcus Biosciences Inc saw a sharp rise in short interest on 2025-05-30 jumping by 3.58 million shares to 11.49 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 7.91 million shares. A jump of 31.17% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.42 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.42.
Which companies own the most shares of Arcus Biosciences Inc (RCUS)?
In terms of Arcus Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 26 in the next 12 months, up nearly 197.14% from the previous closing price of $8.75. Analysts anticipate Arcus Biosciences Inc stock to reach 26 by 2025, with the lowest price target being 26. In spite of this, 3 analysts ranked Arcus Biosciences Inc stock as Buy at the end of 2025. On October 11, 2022, Morgan Stanley assigned a price target of “an Overweight” to the stock and initiated coverage with a $40.
